title: [Ototoxicity of cisplatin chemotherapy in patients with ovarian cancer].
authors.affiliation: Universitäts-Frauenklinik Erlangen.
authors.forename: E
authors.initials: E
authors.lastname: Beck
authors.forename: M
authors.initials: M
authors.lastname: Schuster
authors.forename: A
authors.initials: A
authors.lastname: Berg
authors.forename: W
authors.initials: W
authors.lastname: Jäger
authors.forename: L
authors.initials: L
authors.lastname: Wildt
authors.forename: N
authors.initials: N
authors.lastname: Lang
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001301:Audiometry, Pure-Tone; D002066:Busulfan / Q000008:administration & dosage / Q000031:analogs & derivatives; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced*; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D010865:Pilot Projects
chemical_list: C018404:treosulfan; D002066:Busulfan; D002945:Cisplatin
vernacular_title: Ototoxizität unter cisplatin-haltiger Chemotherapie bei Patientinnen mit Ovarialkarzinomen.